CorMedix Inc. (NASDAQ:CRMD) Q4 2025 Earnings Call Transcript
Operator: Good morning, and welcome to the CorMedix Inc. Fourth Quarter and Full Year 2025 Earnings and Corporate Update Conference Call. Today's conference call is being recorded.
Cormedix Inc. (CRMD)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Royce & Associates Chuck Royce | 1,887,532 | $12,816,342 | +680% | 0.13% |
| 2. | Winton Capital Management David Harding | 38,338 | $260,315 | +75% | 0.01% |
| 3. | 427 | $149,634 | 0.06% | ||
| 4. | Polymer Capital Management Angus Wai | 12,518 | $84,997 | 0.01% | |
| 5. | Caxton Associates LP Bruce Kovner | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $11.02 | 25,000 | $275,500.00 | 201,034 | 2025-10-23 | Filing | |
| $9.99 | 1,500 | $14,984.85 | 52,011 | 2024-10-31 | Filing | |
| $3.74 | 13,561 | $50,718.14 | 352,839 | 2024-03-13 | Filing | |
| $3.30 | 3,000 | $9,900.00 | 15,250 | 2023-12-15 | Filing | |
| $3.45 | 3,000 | $10,350.00 | 12,250 | 2023-12-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.88 | 10,000 | $68,800.00 | 38,473 | 2026-01-21 | Filing | |
| $13.00 | 20,000 | $260,000.00 | 40,250 | 2025-12-30 | Filing | |
| $12.00 | 30,000 | $360,000.00 | 509,496 | 2025-12-18 | Filing | |
| $12.00 | 34,000 | $408,000.00 | 48,473 | 2025-12-09 | Filing | |
| $11.88 | 40,000 | $475,200.00 | 80,498 | 2025-12-09 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 5,967,575 | $40,519,834 | 0% | |
| 2. | 3,129,656 | $21,250,364 | 0% | |
| 3. | 1,538,245 | $10,444,683 | 0% | |
| 4. | 742,571 | $5,042,057 | 0% | |
| 5. | 673,302 | $4,571,721 | 0.1% |
News See All
10 Best Long Term Healthcare Stocks to Buy
Investing in healthcare stocks offers a combination of defensive stability and long-term growth potential, supported by consistent demand for medical services, pharmaceuticals, and healthcare technologies...
H.C. Wainwright Signal Clinical Data to Drive CorMedix Inc. (CRMD) Future Over Commercial Performance
TheFly reported on January 23 that H.C. Wainwright lowered the price target on CRMD to $13 from $18 while keeping a Buy rating.
9 High Growth Small Cap Stocks That Are Profitable
As strategists weigh solid earnings momentum against expensive valuations and longer-term dangers, market opinions are still divided.
Buy Rating Reaffirmed: CorMedix Inc. (CRMD) Posts Profitability and Expands Outlook for 2025
CorMedix Inc. (NASDAQ:CRMD) is one of the best breakout stocks to invest in. On November 13, H.C. Wainwright’s Brandon Folkes reaffirmed a Buy on CorMedix Inc.
10 Best Breakout Stocks to Invest In
The US stock market is running high, hitting record highs, bolstered in part by continued optimism around artificial intelligence.
10 Fast-Growing Small Cap Stocks to Buy According to Analysts
On October 1, Francis Gannon, Co-Chief Investment Officer and Managing Director at Royce Investment Partners, released a report analyzing small-cap performance during the third quarter of 2025.
CorMedix Inc. (NASDAQ:CRMD) Q3 2025 Earnings Call Transcript
Operator: Good day, and welcome to the CorMedix Third Quarter 2025 Earnings and Corporate Update Conference Call. [Operator Instructions] Please note this event is being recorded.
Citizens JMP Reiterates a Buy Rating on CorMedix Inc. (CRMD)
CorMedix Inc. (NASDAQ:CRMD) is one of the best affordable biotech stocks to invest in now. On September 9, Citizens JMP analyst Jason Butler reiterated a Buy rating on CorMedix Inc.
Hedge Fund Resource Center